Laurie Barclay, MD Oct. 9, 2002
Editor’s Note: The Office of the Inspector General (OIG) is reining in the pharmaceutical industry with respect to gifts and other inducements offered to doctors in hopes of increasing sales of their own products. Effective July 1, 2002, the Pharmaceutical Research and Manufacturers of America voluntarily established a Code on Interactions With Health Care Professionals.
On Sept. 30, the OIG went one step further, prohibiting pharmaceutical companies from offering doctors, health plans, or pharmacy benefit managers incentives to encourage or reward the prescribing or purchase of particular drugs. Although these standards have not taken on the force of law, failure to follow them could trigger prosecution for violating anti-kickback laws and other fraud and abuse statutes, both for the pharmaceutical industry and for doctors who collaborate in unethical or even illegal practices.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!